BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8009258)

  • 1. Response of 99mTc-MDP scanning and whole-body retention to intravenous pamidronate.
    Haddaway MJ; Davie MW
    Semin Arthritis Rheum; 1994 Feb; 23(4):280. PubMed ID: 8009258
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous aminohydroxypropylidene bisphosphonate does not modify 99mTc-hydroxymethylene bisphosphonate bone scintigraphy. A prospective study.
    Macro M; Bouvard G; Le Gangneux E; Colin T; Loyau G
    Rev Rhum Engl Ed; 1995 Feb; 62(2):99-104. PubMed ID: 7600079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous pamidronate: evolution of an effective treatment strategy.
    Anderson DC; Richardson PC; Brown JK; Freemont AJ; Hollis S; Denton J; Buckler HM; Hargreaves S; Cantrill JA
    Semin Arthritis Rheum; 1994 Feb; 23(4):273-5. PubMed ID: 8009254
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone uptake of 99mTc-MDP in man: its relationship with local blood flow.
    Vattimo A; Martini G; Pisani M
    J Nucl Med Allied Sci; 1982; 26(3):173-9. PubMed ID: 6184461
    [No Abstract]   [Full Text] [Related]  

  • 5. Dynamic radionuclide study in Paget's disease before and after (Asu1,7) E-calcitonin treatment.
    Vattimo A; Martini G
    J Nucl Med Allied Sci; 1984; 28(3):217-20. PubMed ID: 6241632
    [No Abstract]   [Full Text] [Related]  

  • 6. Three phase 99Tcm (V)DMSA scintigraphy in Paget's disease: an indicator of pamidronate effect.
    Kobayashi H; Shigeno C; Sakahara H; Yamamoto T; Hosono M; Fujimoto R; Konishi J
    Br J Radiol; 1997 Oct; 70(838):1056-9. PubMed ID: 9404211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple method for the assessment of local bone uptake of 99mTc-methylene-diphosphonate.
    Vattimo A; Martini G
    J Nucl Med Allied Sci; 1984; 28(1):23-6. PubMed ID: 6207279
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
    Stuckey BG; Gutteridge DH; Stewart GO; Prince RL; Ward LC; Kent GN; Prince RI; Retallack RW; Bhagat CI; Nicholson GC
    Semin Arthritis Rheum; 1994 Feb; 23(4):286. PubMed ID: 8009263
    [No Abstract]   [Full Text] [Related]  

  • 9. Crescent sign on radionuclide static brain imaging.
    Shih WJ; Domstad PA; DeLand FH
    Semin Nucl Med; 1985 Jan; 15(1):67-9. PubMed ID: 3157218
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative bone scintigraphy in the management of monostotic Paget's disease of bone.
    Patel S; Pearson D; Hosking DJ
    Arthritis Rheum; 1995 Oct; 38(10):1506-12. PubMed ID: 7575701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary vertebral body uptake on bone scintigraphy: the "black ivory" vertebrae sign.
    Greene GS; Maurer AH
    Semin Nucl Med; 1985 Jul; 15(3):317-21. PubMed ID: 2930900
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone scintigraphy in evaluation of Didronel therapy for Paget's disease.
    Lee JY
    Clin Nucl Med; 1981 Aug; 6(8):356-8. PubMed ID: 6455232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical comparison of MDP and DMAD.
    Rosenthall L; Stern J; Arzoumanian A
    Clin Nucl Med; 1982 Sep; 7(9):403-6. PubMed ID: 6214358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observations on serial radionuclide blood-flow studies in Paget's disease: concise communication.
    Boudreau RJ; Lisbona R; Hadjipavlou A
    J Nucl Med; 1983 Oct; 24(10):880-5. PubMed ID: 6225840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole body retention of Tc-99m phosphate in Paget's disease of bone.
    Hadjipavlou A; Lisbona R; Garbuz D; Abibtbol JJ
    Clin Nucl Med; 1991 Jun; 16(6):435-8. PubMed ID: 1868658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of 24-hr whole-body retention of 99mTc-MDP with a thyroid uptake probe (author's transl)].
    Seto H; Kakishita M; Futatsuya R
    Radioisotopes; 1981 May; 30(5):263-7. PubMed ID: 6458840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of the kinetics of bone concentration of mdp-tc 99m in Paget's disease and various treatment methods].
    de La Rochefoucauld B; Basset JY; Rondier J; Cayla J; Ancri D
    Rev Rhum Mal Osteoartic; 1984 Nov; 51(10):575-9. PubMed ID: 6241965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body retention of 99mTc-MPD in Paget's disease.
    Vattimo A; Cantalupi D; Righi G; Martini G; Nuti R; Turchetti V
    J Nucl Med Allied Sci; 1981; 25(1-2):5-10. PubMed ID: 6454766
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
    Grauer A; Klar B; Scharla SH; Zieglar R
    Semin Arthritis Rheum; 1994 Feb; 23(4):283-4. PubMed ID: 8009261
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Paget's disease of bone with single-dose intravenous pamidronate.
    Watts RA; Skingle S; Bhambani M; Pountain G; Crisp AJ
    Semin Arthritis Rheum; 1994 Feb; 23(4):281. PubMed ID: 8009259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.